Stephen Parmley, PhD

AnaptysBio
San Diego, California, United States

Disclosure information not submitted.

Presentation(s):

• Rosnilimab, a PD-1 Agonist Antibody That Binds to a Membrane Proximal Epitope Leading to Optimized PD-1 Agonistic Signaling

  Thursday, June 20, 2024
  3:30 PM – 3:45 PM PT